您好，欢迎来到国际肝病网！

其他专题：APASL|APASL2014 |APASL2013|APASL2012|APASL2011|APASL2010|APASL2009|国际肝病

乙肝

专题首页 » 乙肝

⇔ 解读指南，更新指南——APASL主席Omata教授现场采访 2009-12-11
⇔ Treatment Goals: Can Chronic Hepatitis B be Cured? The View of the Virologist 2007-12-10
⇔ Treatment Goals: Can Chronic Hepatitis B be Cured? In the view of hepatologist 2007-12-10
⇔ Current Optimal HBV Treatment in HBeAg-positive patients 2007-12-10
⇔ Update in natural history of HBV infection; Do we really understand it? 2007-12-10
⇔ There is still a role for interferon in the treatment of HBeAg negative CHB PRO 2007-12-10
⇔ There is still a role for interferon in the treatment of HBeAg negative CHB CON 2007-12-10
⇔ HBV in immunosuppression, chemotherapy & transplant recipients 2007-12-10
⇔ Severe Acute Hepatitis B Treat 2007-12-10
⇔ Severe Acute Hepatitis B Not To Treat 2007-12-10
⇔ Chronic Hepatitis B - Predictive factors for disease progression 2007-12-10
⇔ Predictability in Chronic HBV – Treatment Response 2007-12-10
⇔ Management of CHB with Normal ALT 2007-12-10
⇔ Update APASL consensus on management of chronic hepatitis B 2007-12-10
⇔ Controversies in the Therapy of CHB–When to start? 2007-12-07
⇔ Controversies in the Therapy of CHB–When to stop? 2007-12-07
⇔ Asia Hep Symposium On Controversies in Therapy of Hepatitis B: When to Alter 2007-12-06
⇔ Controversies in the therapy of Hepatitis B Infection: When to Monitor 2007-12-06
⇔ CONTROVERSIES IN THE THERAPY OF HEPATITIS B INFECTIONPREDICTOR OF COMPLICATIONS 2007-12-06

首页 1 尾页

专题标签

学术领域

扫描二维码，用手机看今日话题